Dropped as an anti-rejection drug, daclizumab is back with a new indication in MS

COMET could allow precise spatiotemporal targeting of disease-controlling mechanisms

Jennifer Van Eyk shares her vision for our clinical proteomic future

A new blood-filtering device could save lives in the fight against malaria

Cell therapies for Type 1 diabetes aim to make hypoglycemic attacks a thing of the past

Previously thought to be "junk", long noncoding RNAs may play a central role in cancer

Is the "Cancer Moonshot" approach to research really a viable solution?

When biomarkers aren't an option in vaccine research, we need a well-supported alternative

An upcoming issue will celebrate the best images from across the translational field

NIDA has launched a $100,000 competition to encourage startup companies